Cabaletta Bio Reports Q2 2026 Financial Results

What Happened
On August 13, 2026, Cabaletta Bio, Inc. announced its financial results for the second quarter ended June 30, 2026 via a press release and filed a Form 8-K (Item 2.02) to report those results. The press release is furnished as Exhibit 99.1 to the Form 8-K. The report was signed by CEO and President Steven Nichtberger.

Key Details

• Filing date: August 13, 2026 (Form 8-K).
• Reporting item: Item 2.02 — Results of Operations and Financial Condition (quarter ended June 30, 2026).
• Exhibit: Press release furnished as Exhibit 99.1.
• Signature: Report signed by Steven Nichtberger, Chief Executive Officer and President.

Why It Matters
This 8-K signals that Cabaletta has released its quarterly earnings and other financial information for Q2 2026. Investors should review the furnished press release (Exhibit 99.1) and any related disclosures for specific figures—revenue, expenses, cash position or guidance—that could affect the company’s valuation and near-term stock performance. The filing itself confirms the official release of those results and the company’s executive signatory.